Pathkey.AI Ltd (ASX:PKY)
Australia
· Delayed Price · Currency is AUD 0.0240
0.00 (0.00%)
At close: Mar 6, 2026
Pathkey.AI Company Description
Pathkey.AI Ltd, a digital health company, involves artificial intelligence (AI) to improve clinical trials and predicting outcomes for patients in Australia.
The company offers TrialKey, an AI-driven clinical trial optimization and success prediction platform, that simulate and optimize trial designs.
It also provides TrialGen, an AI-powered tool streamlines clinical trial design process. The company serves biopharma, MedTech, government, and healthcare organizations.
The company was formerly known as Opyl Limited and changed its name to Pathkey.AI Ltd in August 2025.
Pathkey.AI Ltd was incorporated in 1994 and is based in Sydney, Australia.
Pathkey.AI Ltd
| Country | Australia |
| Founded | 1994 |
| Industry | Health Information Services |
| Sector | Healthcare |
| CEO | Saurabh Jain |
Contact Details
Address: 6 Middlemiss Street Sydney, NSW 2060 Australia | |
| Phone | 61 3 9923 1222 |
| Website | pathkey.ai |
Stock Details
| Ticker Symbol | PKY |
| Exchange | Australian Securities Exchange |
| Fiscal Year | July - June |
| Reporting Currency | AUD |
| ISIN Number | AU0000415291 |
| SIC Code | 1000 |
Key Executives
| Name | Position |
|---|---|
| Damon Rasheed | Founder, Chief Technology Officer and Executive Director |
| Mark Ziirsen | Chief Financial Officer |
| Bernice Averion | Head of Marketing and Communications |
| Shane Lewis | Vice President of Sales and Partnerships |
| Matt Hallam | Chief Revenue Officer |
| Jonathan Hart B.Com., L.L.B. | Company Secretary |